Suppr超能文献

超越 KCH 选择和急性肝衰竭的治疗方案。

Beyond KCH selection and options in acute liver failure.

机构信息

The Institute of Liver Studies, Cheyne Wing, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.

The Institute of Hepatology London and Foundation for Liver Research, 111 Coldharbour Lane, London, SE5 9NT, UK.

出版信息

Hepatol Int. 2018 May;12(3):204-213. doi: 10.1007/s12072-018-9869-7. Epub 2018 Jun 1.

Abstract

The King's prognostic criteria for patients with acute liver failure (ALF) introduced in 1989 have been used worldwide. This distinguished for the first time cases with 'hyper-acute' course (characteristically paracetamol overdose) where there is a better chance of recovery with medical supportive care alone from those etiologies with a less acute course and paradoxically lower chances of 'spontaneous' recovery. Ongoing use showed the limited sensitivity of the criteria to constitute a significant practical limitation. Subsequent models including the MELD score and composite ones with markers of necrosis, an apoptotic liver cell death, proposed to improve sensitivity did not have the required high specificity. Two recent models utilizing new availability of web- and app-based computing delivering outcome predication through sophisticated algorithms are described. The first is a dynamic model described for paracetamol-induced ALF based upon admission findings and sequential variables over the first 2 days. The new model of the US Acute Liver Failure group was devised to cover all etiologies of ALF for predicting 'transplant-free' survival and accurately predicated spontaneous survival in two-thirds of cases. Improved survival results with medical management, particularly in hyper-acute cases, now approach those obtained with successful liver transplant and have raised the question of transplant benefit. Also considered in the review are new non-transplant approaches to treatment including the use of plasma exchange and based on successful results in acute-on-chronic liver failure, agents to modulate and improve hepatic regeneration.

摘要

1989 年引入的用于急性肝衰竭(ALF)患者的 King 预后标准已在全球范围内使用。这首次区分了具有“超急性”病程的病例(特征为对乙酰氨基酚过量),仅通过医学支持治疗就有更好的恢复机会,而那些病程不太急性的病因则恢复机会较低,且具有“自发”恢复的悖论。持续使用表明,这些标准的敏感性有限,构成了一个显著的实际限制。随后的模型,包括 MELD 评分和结合坏死标志物的综合模型,提出提高敏感性,但特异性不够高。本文描述了两种最近的利用网络和基于应用程序的计算新方法,通过复杂的算法来提供预后预测。第一个是描述基于入院时发现和前 2 天内连续变量的乙酰氨基酚诱导的 ALF 的动态模型。美国急性肝衰竭组的新模型旨在涵盖所有 ALF 的病因,用于预测“无移植”存活率,并准确预测三分之二病例的自发存活率。通过医疗管理提高了存活率,特别是在超急性病例中,现在接近成功肝移植的存活率,并提出了移植益处的问题。该综述还考虑了新的非移植治疗方法,包括使用血浆置换以及基于急性慢性肝衰竭的成功结果,调节和改善肝再生的药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验